IL100690A - A method for the production of auto-antibodies that react with antigens of auto-immune disease - Google Patents

A method for the production of auto-antibodies that react with antigens of auto-immune disease

Info

Publication number
IL100690A
IL100690A IL10069092A IL10069092A IL100690A IL 100690 A IL100690 A IL 100690A IL 10069092 A IL10069092 A IL 10069092A IL 10069092 A IL10069092 A IL 10069092A IL 100690 A IL100690 A IL 100690A
Authority
IL
Israel
Prior art keywords
lymphocytes
mammal
cells
autoantibodies
reconstituted
Prior art date
Application number
IL10069092A
Other languages
English (en)
Hebrew (he)
Other versions
IL100690A0 (en
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of IL100690A0 publication Critical patent/IL100690A0/xx
Publication of IL100690A publication Critical patent/IL100690A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Forging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
IL10069092A 1991-01-18 1992-01-17 A method for the production of auto-antibodies that react with antigens of auto-immune disease IL100690A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK009091A DK9091D0 (da) 1991-01-18 1991-01-18 Fremgangsmaade til fremstilling af antistoffer

Publications (2)

Publication Number Publication Date
IL100690A0 IL100690A0 (en) 1992-09-06
IL100690A true IL100690A (en) 1996-09-12

Family

ID=8089624

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10069092A IL100690A (en) 1991-01-18 1992-01-17 A method for the production of auto-antibodies that react with antigens of auto-immune disease

Country Status (11)

Country Link
EP (1) EP0567532B1 (da)
JP (1) JPH06504675A (da)
KR (1) KR930703433A (da)
AT (1) ATE140727T1 (da)
AU (1) AU655001B2 (da)
DE (1) DE69212461T2 (da)
DK (2) DK9091D0 (da)
ES (1) ES2091459T3 (da)
GR (1) GR3021293T3 (da)
IL (1) IL100690A (da)
WO (1) WO1992013065A1 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9810040D0 (en) 1998-05-11 1998-07-08 Univ Nottingham Blood borne tumour markers
GB9827228D0 (en) 1998-12-10 1999-02-03 Univ Nottingham Cancer detection method and reagents
AU2001289930A1 (en) * 2000-09-25 2002-04-08 Rega Stichting Vzw Method for the production of human antibodies, antibodies thus obtained and their use in therapy and diagnosis
GB2424273B (en) 2002-11-14 2007-06-27 Univ Nottingham Method for preparing tumour marker protein
RU2636532C2 (ru) 2005-05-27 2017-11-23 Онкиммьюн Лимитед Улучшенные способы иммуноанализа
GB2426581A (en) 2005-05-27 2006-11-29 Univ Nottingham Immunoassay methods
CN101632020B (zh) 2006-09-13 2013-11-27 昂西免疫有限公司 改进的免疫测定方法
WO2013098419A1 (en) 2011-12-28 2013-07-04 Immunoqure Ag Method of providing monoclonal auto-antibodies with desired specificity

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0322240B1 (en) * 1987-12-23 1995-03-01 The Board Of Trustees Of The Leland Stanford Junior University Chimeric immunocompromised mammals and their use
JP2981486B2 (ja) * 1988-06-14 1999-11-22 メディカル・バイオロジー・インスティチュート 哺乳動物の免疫系研究方法
AU637914B2 (en) * 1990-05-03 1993-06-10 Systemix, Inc. Human lymphoid tissue in an immunocompromised host

Also Published As

Publication number Publication date
AU1185592A (en) 1992-08-27
ES2091459T3 (es) 1996-11-01
IL100690A0 (en) 1992-09-06
EP0567532B1 (en) 1996-07-24
ATE140727T1 (de) 1996-08-15
WO1992013065A1 (en) 1992-08-06
AU655001B2 (en) 1994-12-01
DK0567532T3 (da) 1996-11-11
EP0567532A1 (en) 1993-11-03
GR3021293T3 (en) 1997-01-31
DK9091D0 (da) 1991-01-18
DE69212461D1 (de) 1996-08-29
KR930703433A (ko) 1993-11-30
DE69212461T2 (de) 1996-12-12
JPH06504675A (ja) 1994-06-02

Similar Documents

Publication Publication Date Title
Weetman et al. Autoimmune thyroid disease: developments in our understanding
JP4242446B2 (ja) 糖尿病及びスティフマン症候群の診断及び治療用改良試薬及び方法
KR100216097B1 (ko) 자가면역 및 악성종양질환 치료제로서의 t세포 수용체 펩티드
JPH09502096A (ja) 抗ｇｐ３９抗体およびその用途
JP3025271B2 (ja) 無細胞ｔ細胞抗原レセプターおよびその臨床的利用
JPH06502916A (ja) 糖尿病自己抗体の検出方法
JPS61502026A (ja) サイトメガロウイルスの検定のための診断系
EP0567532B1 (en) A method of producing autoantibodies
US7732147B2 (en) Neurotransmission disorders
Brocke et al. The autoimmune response of different mouse strains to T-cell epitopes of the human acetylcholine receptor alpha subunit.
CN117777297A (zh) 抗内源性pink1蛋白的单克隆抗体及其应用
CN117074674B (zh) 检测N-乙酰-β-D氨基葡萄糖苷酶的胶体金试纸及其制备方法
Spuler et al. Thymoma-associated myasthenia gravis. Transplantation of thymoma and extrathymomal thymic tissue into SCID mice.
Teale et al. A clonal analysis of the IgE response and its implications with regard to isotope commitment.
Wauben et al. Inhibition of experimental autoimmune myasthenia gravis by major histocompatibility complex class II competitor peptides results not only in a suppressed but also in an altered immune response
JP4071330B2 (ja) 抗ヒトメダラシンモノクローナル抗体、その製造方法及びそれを用いる免疫学的測定方法
Conti-Tronconi et al. Stimulation of lymphocytes by cholinergic receptor in myasthenia gravis
US7993647B2 (en) Monoclonal antibodies to HIV-1 and methods of using same
PL205979B1 (pl) Sposób immunologicznego pomiaru zawartości ludzkiej medullazyny i sposób diagnozowania stwardnienia rozsianego
JP7101252B2 (ja) 末梢神経障害を診断及び／又は治療するための方法及びキット
EP0582450A2 (en) Anti-oxytocin receptor antibodies and methods for their production
Wang et al. The B‐cell repertoire in myasthenia gravis includes all four acetylcholine receptor subunits
Moncayo et al. Islet cell antigens: extraction studies and ELISA analysis
Wemlinger Anti-Human CD79 Therapeutic Monoclonal Antibodies: Induction of B Cell Anergy and Translational Studies for Prospective Use in the Treatment of Human Autoimmune Disease
Edelman et al. Monoclonal antibodies against blood group antigens

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees